Last reviewed · How we verify
OXITRIPTAN
At a glance
| Generic name | OXITRIPTAN |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- 5HTP Regulation Of Asthma In Children (PHASE2)
- Tinnitus and Treatment With umPEA-LUT (NA)
- A Replicate Crossover Trial on Nutritional Supplementation in Association Football (Soccer) (NA)
- Effects of 5HTP on the Injured Human Spinal Cord (PHASE2, PHASE3)
- 5-HTP and Creatine for Depression R33 Phase (PHASE2)
- The Effect of Griffonia Simplicifolia on Pain Intensity, Central and Peripheral Sensitization, Painmodulation in Healthy Volunteers (NA)
- Effects of Daily Supplementation of 5-HTP on Body Composition (NA)
- Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OXITRIPTAN CI brief — competitive landscape report
- OXITRIPTAN updates RSS · CI watch RSS